Regencell Bioscience
5 hedge funds and large institutions have $296K invested in Regencell Bioscience in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
5
Holders Change
–
Holders Change %
0%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
1
Qube Research & Technologies (QRT)
London,
United Kingdom
|
$0 |
| 2 |
2
Citigroup
New York
|
$0 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
Geode Capital Management
Boston,
Massachusetts
| $238K | +$238K | +259,008 | New |
|
2
UBS Group
Zurich,
Switzerland
| $25K | +$16.6K | +18,202 | +196% |
|
|
TRCT
3
Tower Research Capital (TRC)
New York
| $20K | +$5.05K | +5,548 | +34% |
|
4
BlackRock
New York
| $8K | +$8K | +9,044 | New |
|
5
Morgan Stanley
New York
| $5K | +$4.8K | +5,434 | +2,383% |
|
|
6
Qube Research & Technologies (QRT)
London,
United Kingdom
| – | -$371K | -658,502 | Closed |
|
|
7
Citigroup
New York
| – | -$48K | -85,120 | Closed |
|